V-Go Insulin Delivery

v-go insulin delivery, v-go insulin patch

V-Go Insulin Delivery

Make multiple daily injections a thing of the past and simplify diabetes with V-Go

v-go insulin delivery, v-go insulin patch

Simple All-Day-and-Night Insulin Delivery

Insulin delivery that’s worn like a patch! V-Go is designed to easily fit into your life and help you manage diabetes by combining all of your insulin needs into one simple patch-like device. No more insulin pens or syringes! V-Go supplies insulin in two ways, similar to the way your body produces insulin:

  • Provides a steady rate of background insulin over a 24-hour period

  • Discreetly provides additional insulin at mealtimes by simply clicking a button

By using V-Go, you can live your life on the go without stopping to gather supplies or look for a private place to give yourself an injection.

If you have Type 2 diabetes and are taking multiple daily injections, the V-Go insulin delivery system may be the perfect solution for you.

Benefits of V-Go Insulin Delivery

The iLet Bionic Pancreas from Beta Bionics automatically adjusts to your insulin needs so you don’t have to.

Lowers A1C while using less insulin as compared to multiple daily injections (MDIs)1,2. With V-GO, there is no need to carry insulin pens, syringes. or vials. It is so discreet, nobody will know you’re using it — even at mealtimes. There is no batteries, tubes, or programming needed!

Simple diabetes management*

  • Control blood glucose 24/7

  • Apply like a patch once a day

  • Easily comply with your treatment regimen

  • Deliver 20, 30, or 40 units of insulin in one 24-hour period and on-demand bolus dosing in 2-unit increments

V-Go is reimbursed by many commercial insurances

  • Only fast-acting insulin used — no need for long-acting insulin

  • Many V-Go customers use insulin more efficiently, wasting less and using less, ultimately saving money

  • No more copays for needles or syringes, saving even more money

References 1. Harrison HC, Everitt B, Nikkel C. Poster: The Impact of utilizing a novel insulin delivery device in patients with type 2 diabetes. Presented at ACCE. May 2017. 2. Lajara R, Nikkel C. Poster: Evaluating the effect of V-Go® therapy in sub-optimally controlled patients with diabetes: a retrospective cohort analysis on a large specialized diabetes system. Presented at ACCE. May 2015. 3. Lajara R, Nikkel C. Poster presented at: the International Society for Pharmacoeconomics and Outcomes Research 22nd Annual International Meeting; May 2017; Boston, MA.

Instructions for Patient Use

V-Go Patient Resources

Important Safety Information
V-Go is magnetic resonance (MR) unsafe. V-Go should be removed before an X-ray, MRI or CT scan and replaced with a new V-Go after the test is completed. V-Go should not be used with other insulin products unless instructed by a healthcare professional.
The V-Go series of Wearable Insulin Delivery devices are indicated for continuous subcutaneous infusion of either 20 Units of insulin (0.83 U/hr), 30 Units of insulin (1.25 U/hr) or 40 Units of insulin (1.67 U/hr) in one 24-hour time period and on-demand bolus dosing in 2 Unit increments (up to 36 Units per one 24-hour time period) in adults requiring insulin.